PHARMA-BIO SERV, INC. (PBSV) Free cash flow 2016–2025
PHARMA-BIO SERV, INC. (PBSV) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$221,530FY2025 · since FY2016: -$1.1M → -$221,530
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$221,530 | +69.5% |
| FY2024 | -$726,444 | -138.6% |
| FY2023 | $1.9M | +228.6% |
| FY2022 | $573,188 | -27.8% |
| FY2021 | $793,997 | -45.6% |
| FY2020 | $1.5M | +164.4% |
| FY2019 | -$2.3M | -163.0% |
| FY2018 | $3.6M | +467.1% |
| FY2017 | -$979,640 | +10.9% |
| FY2016 | -$1.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice